Misoprostol for abortion up to 9 weeks' gestation in adolescents

European Journal of Contraception and Reproductive Health Care

Volumn 5, Issue 4, 2000, Pages 227-233

  Velazco, A ^a   Varela, L ^a   Tanda, R ^a   Sanchez C ^a   Barambio, S ^b   Chami, S ^c   Valero, F ^d   Aragon S ^e   Mari J ^e   Carbonell, J L L ^e  

^a Hospital Gineco Obstétrico 'Eusebio Hernández' Maternidad Obrera   (Cuba)

^b Clinica Tutor Medica   (Spain)

^c Clinica Isadora   (Spain)

^d Clinica Delta Medica   (Spain)

^e Mediterranea Medica Clinic   (Spain)

Author keywords

Abortion; Adolescents; Misoprostol

Indexed keywords

MISOPROSTOL; PARACETAMOL;

ABORTION; ADOLESCENCE; ADOLESCENT; ADOLESCENT PREGNANCY; ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; NAUSEA; OUTCOMES RESEARCH; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; VAGINA BLEEDING; VOMITING;

EID: 0034472992     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/13625180008500410     Document Type: Article

References (10)

1. Abortion training in obstetrics and gynecology residency programs in the United States, 1991-1992
2. Pregnancy, abortion and birth rates among US adolescents - 1980, 1985, and 1990
3. Methotrexate and misoprostol for early abortion in adolescent women
4. Early abortion with 800 μg of misoprostol by the vaginal route
5. The use of misoprostol for termination of early pregnancy
6. The use of misoprostol for abortion of ≤ 9 weeks' gestation
7. Growth and development of the human fetus prior to the twentieth week of gestation
8. Analysis of failure in medical abortion
9. Approaches to sample size estimations in the design of clinical trials